Awards Registry

Chemical Casualty Care: Hydrogel Nanoparticle Aggregates as Wound Dressings Following Debridement of Cutaneuous Vesicant Injuries
Profile last edited on: 2/19/07

Program
SBIR
Agency
Army
Total Award Amount
$69,988
Award Phase
1
Principal Investigator
John V St John
Activity Indicator

Company Information

Abeona Therapeutics Inc (AKA:PlasmaTech Biopharmaceutcials Inc~Access Pharmaceuticals Inc~Chemex Corporation~Chemex Pharmaceuticals Inc)

1330 Avenue of the Americas 33rd Floor
New York, NY 20029
   (214) 905-5100
   info@abeonatherapeutics.com
   www.abeonatherapeutics.com
Multiple Locations:   
Congressional District:   32
County:   Dallas

Phase I

Phase I year
2006
Phase I Amount
$69,988
The proposed research will demonstrate the utility of hydrogel nanoparticle aggregates as bandages for post-debridement vesicant injuries. Dehydrated hydrogel nanoparticles in powder form are applied to the surface of a wound. The nanoparticles aggregate immediately and form a continuous hydrogel film that absorbs exudate and protects the wound surface. Studies show that an aggregate film controls the release of antibiotics, painkillers, protein-based growth factors, and steroids for periods ranging from weeks to months. The research will apply the wound dressing to burns in an animal model and assess the healing and local pharmacokinetics for released therpeutics

Phase II

Phase II year
---
Phase II Amount
---